Numerous blood tests and brain scans failed to generate ... point to the possibility that in at least a subset of schizophrenia cases, the immune system is the culprit. Many research groups continue ...

If the FDA follows an advisory committee’s vote, it can potentially be a transformative step in the delivery of mental health ...

There is no lab test that confirms or rules out a diagnosis of schizophrenia. Blood, urine ... as a family, or as a group with other families. ACT aims to reduce the number of hospitalizations ...

Caplyta (lumateperone) was approved for the treatment of schizophrenia in 2019 and for ... antipsychotics may lead to weight gain, high blood pressure, diabetes, or high cholesterol.

Standard alcohol drinks in a scheduled design were administered to produce blood alcohol levels ... reported only in the context of group comparisons with schizophrenia patients.